Nicole L Johnson1, Katharine J Head1, Susanna Foxworthy Scott2, Gregory D Zimet3. 1. 10668 Indiana University-Purdue University Indianapolis, Indianapolis, IN, USA. 2. 10668 Indiana University Simon Cancer Center, Indianapolis, IN, USA. 3. 10668 Division of Adolescent Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Abstract
OBJECTIVES: Cervical cancer is the second-most common type of cancer among women aged 15-44, and racial, ethnic, and economic disparities exist in survival rates despite widely available screening tests and early treatment options. The objective of this study was to describe the association among knowledge, sociodemographic characteristics, and cervical cancer screening, with the goal of developing interventions to prevent cervical cancer in populations at risk of the disease. METHODS: In 2017, we conducted a nationwide survey of women in the United States aged ≥18 who had ever received a Papanicolaou (Pap) test (N = 630). We conducted t tests and one-way analysis of variance to determine sociodemographic differences (age, education, race, ethnicity, income, type of health insurance) in knowledge about cervical cancer screening (Pap test and human papillomavirus [HPV] test). We used logistic regressions to define significant determinants of cervical cancer screening behaviors in the previous 5 years. RESULTS: Of 629 respondents, 407 (64.7%) had an annual household income <$30 000, and 322 of 536 (60.1%) respondents had government-provided health insurance. Of 630 women who had ever had a Pap test, 425 (67.5%) had an HPV test. Hispanic and non-Hispanic white women were more likely than Hispanic and non-Hispanic black women (odds ratio [OR] = 2.49; 95% CI, 1.12-4.54; P = .02) and women with government-provided health insurance (OR = 1.91; 95% CI, 1.08-3.37; P = .03) were more likely than women with private health insurance to have received a Pap test in the previous 5 years. Knowledge of HPV was a significant predictor of having received an HPV test in the previous 5 years (OR = 1.37; 95% CI, 1.22-1.54; P < .001). CONCLUSION: Disparities in cervical cancer screening among sociodemographic groups of women suggest the need for targeted interventions to improve knowledge about Pap and HPV tests.
OBJECTIVES: Cervical cancer is the second-most common type of cancer among women aged 15-44, and racial, ethnic, and economic disparities exist in survival rates despite widely available screening tests and early treatment options. The objective of this study was to describe the association among knowledge, sociodemographic characteristics, and cervical cancer screening, with the goal of developing interventions to prevent cervical cancer in populations at risk of the disease. METHODS: In 2017, we conducted a nationwide survey of women in the United States aged ≥18 who had ever received a Papanicolaou (Pap) test (N = 630). We conducted t tests and one-way analysis of variance to determine sociodemographic differences (age, education, race, ethnicity, income, type of health insurance) in knowledge about cervical cancer screening (Pap test and human papillomavirus [HPV] test). We used logistic regressions to define significant determinants of cervical cancer screening behaviors in the previous 5 years. RESULTS: Of 629 respondents, 407 (64.7%) had an annual household income <$30 000, and 322 of 536 (60.1%) respondents had government-provided health insurance. Of 630 women who had ever had a Pap test, 425 (67.5%) had an HPV test. Hispanic and non-Hispanic white women were more likely than Hispanic and non-Hispanic black women (odds ratio [OR] = 2.49; 95% CI, 1.12-4.54; P = .02) and women with government-provided health insurance (OR = 1.91; 95% CI, 1.08-3.37; P = .03) were more likely than women with private health insurance to have received a Pap test in the previous 5 years. Knowledge of HPV was a significant predictor of having received an HPV test in the previous 5 years (OR = 1.37; 95% CI, 1.22-1.54; P < .001). CONCLUSION: Disparities in cervical cancer screening among sociodemographic groups of women suggest the need for targeted interventions to improve knowledge about Pap and HPV tests.
Entities:
Keywords:
HPV knowledge; Pap test knowledge; cervical cancer screening; high-risk populations; human papillomavirus (HPV)
Authors: Warner K Huh; Kevin A Ault; David Chelmow; Diane D Davey; Robert A Goulart; Francisco A R Garcia; Walter K Kinney; L Stewart Massad; Edward J Mayeaux; Debbie Saslow; Mark Schiffman; Nicolas Wentzensen; Herschel W Lawson; Mark H Einstein Journal: Obstet Gynecol Date: 2015-02 Impact factor: 7.661
Authors: JudyAnn Bigby; Linda K Ko; Natacha Johnson; Michele M A David; Barbara Ferrer Journal: Public Health Rep Date: 2003 Jul-Aug Impact factor: 2.792
Authors: Isabel C Scarinci; Francisco A R Garcia; Erin Kobetz; Edward E Partridge; Heather M Brandt; Maria C Bell; Mark Dignan; Grace X Ma; Jane L Daye; Philip E Castle Journal: Cancer Date: 2010-06-01 Impact factor: 6.860
Authors: Xuan Zhu; Kathy L MacLaughlin; Chun Fan; Debra J Jacobson; Gregory D Jenkins; Robert M Jacobson; Lila J Finney Rutten Journal: J Gen Intern Med Date: 2021-05-13 Impact factor: 6.473
Authors: Katie E Lichter; Kimberly Levinson; Anne Hammer; Melissa H Lippitt; Anne F Rositch Journal: Gynecol Oncol Date: 2022-02-01 Impact factor: 5.482
Authors: Emily A Burger; Inge M C M de Kok; James F O'Mahony; Matejka Rebolj; Erik E L Jansen; Daniel D de Bondt; James Killen; Sharon J Hanley; Alejandra Castanon; Jane J Kim; Karen Canfell; Megan A Smith; Mary Caroline Regan Journal: medRxiv Date: 2022-07-25
Authors: Whitney L Hensing; Steven P Poplack; Cheryl R Herman; Siobhan Sutcliffe; Graham A Colditz; Foluso O Ademuyiwa Journal: Cancer Date: 2021-04-01 Impact factor: 6.921